Brief: Ikena Oncology Reports First Quarter 2023 Financial Results And Highlights Advancements Across Targeted Oncology Pipeline

ImageneBio

15/05/2023 12:57

Ikena Oncology Inc  IKNA.O :
    * IKENA ONCOLOGY REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND
HIGHLIGHTS ADVANCEMENTS ACROSS TARGETED ONCOLOGY PIPELINE
    * IKENA ONCOLOGY INC - UNDERWRITTEN OFFERING OF $40M EXTENDS
RUNWAY INTO 2026
    * IKENA ONCOLOGY INC - QTRLY LOSS PER SHARE $0.39
    * IKENA ONCOLOGY INC - IK-930, CONTINUES TO ADVANCE THROUGH
DOSE
ESCALATION WITH NO DOSE-LIMITING TOXICITIES OBSERVED TO-DATE

Source text for Eikon:  ID:nGNX8Tyldn 
Further company coverage:  IKNA.O